At present, there are 7 kinds of human coronaviruses: HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, HCoV-HKU1, MERS-CoV, and novel coronavirus (2019-nCoV), that are the important pathogens of human respiratory tract infection. Among them, novel coronavirus (2019-nCoV) presents clinical manifestations of fever, fatigue, and other systemic symptoms, accompanied by dry cough, dyspnea, etc. Can rapidly develop into severe pneumonia, respiratory failure, acute respiratory distress syndrome, septic shock, multiple organ failure, severe acid and base metabolism disorders, and even life-threatening. It is very necessary to carry out an effective antibody covid test through the covid antibody test kit. 2019-nCoV Antibody Test Kit (Nephelometry Immunoassay Method) produced by Shijiazhuang Hipro Biotechnology Co., Ltd can be used for in vitro qualitative detection of IgM and IgG antibodies against novel coronavirus in human serum.
Testing Principle of 2019-nCoV IgM/IgG Antibody Test Kit (Nephelometry immunoassay Method)
The earliest antibody produced by the human body after being infected by 2019-nCoV is IgM antibody, which is generally produced 3-7 days after infection and replaced by IgG antibody produced in large quantities about two weeks later.
Therefore, 2019-nCoV specific antibodies IgM and IgG can be used as auxiliary means for the diagnosis of suspected patients.
The 2019-nCoV recombinant protein antigen was coated on the latex particles, and the 2019-nCoV antibody IgM/IgG in the sample was specifically combined with the corresponding antigen-sensitized latex in the reagent to form the antigen-antibody complex,